Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Toni Chancellor
Introduction
Toni Chancellor is a notable inventor based in San Carlos, California. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for KDM1A. His work is characterized by a focus on innovative methods and processes that advance scientific understanding and therapeutic applications.
Latest Patents
Toni Chancellor holds one patent titled "Methods and processes for the preparation of KDM1A inhibitors." This patent discloses methods for the synthesis of substituted 2-arylcyclopropylamines and 2-heteroarylcyclopropylamines, along with related compounds. Additionally, it provides methods for the reduction of thioesters to aldehydes and methods for the reductive amination of cyclopropylamines. These advancements are crucial for developing new therapeutic strategies.
Career Highlights
Chancellor is currently associated with Imago Biosciences, Inc., where he applies his expertise in biochemistry to drive innovation. His work at the company reflects a commitment to advancing medical science through the development of novel compounds.
Collaborations
Some of his coworkers include Amy E. Tapper and Cassandra Celatka, who contribute to the collaborative environment at Imago Biosciences, Inc. Their combined efforts enhance the research and development initiatives within the company.
Conclusion
Toni Chancellor's innovative work in the field of biochemistry, particularly through his patent on KDM1A inhibitors, showcases his dedication to advancing medical science. His contributions are vital for the development of new therapeutic options.